Biotech · Private company
Promontory Therapeutics Inc.
Track this companyFree. Adds Promontory Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- avelumabPhase 2 · Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- PT-112Phase 2 · Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
- PT-112 InjectionPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PT-112Phase 1 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With AvelumabPHASE1_PHASE2 · COMPLETED · started Apr 24, 2018ClinicalTrials.gov NCT03409458 · fetched Nov 12, 2026
- A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple MyelomaPHASE1 · COMPLETED · started Dec 15, 2017ClinicalTrials.gov NCT03288480 · fetched Nov 12, 2026
- A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion CohortsPHASE2 · UNKNOWN · started Jul 1, 2014ClinicalTrials.gov NCT02266745 · fetched Nov 12, 2026